Community Healthcare Trust (CHCT) 10-Q 7 Aug 18 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Jul. 31, 2018
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Entity Registrant Name	Community Healthcare Trust Inc
Entity Central Index Key	1,631,569
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		18,199,975

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Real estate properties
Land and land improvements	$ 47,080	$ 44,419
Buildings, improvements, and lease intangibles	369,563	343,955
Personal property	129	112
Total real estate properties	416,772	388,486
Less accumulated depreciation	(45,682)	(36,136)
Total real estate properties, net	371,090	352,350
Cash and cash equivalents	1,784	2,130
Mortgage note receivable, net	0	10,633
Other assets, net	37,910	20,653
Total assets	410,784	385,766
Liabilities
Debt, net	125,417	93,353
Accounts payable and accrued liabilities	4,439	4,056
Other liabilities	4,570	4,983
Total liabilities	134,426	102,392
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,199,975 and 18,085,798 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively	182	181
Additional paid-in capital	325,719	324,303
Cumulative net income	9,064	4,775
Accumulated other comprehensive income	2,039	258
Cumulative dividends	(60,646)	(46,143)
Total stockholders’ equity	276,358	283,374
Total liabilities and stockholders' equity	$ 410,784	$ 385,766

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized	450,000,000	450,000,000
Common Stock, shares issued	18,199,975	18,085,798
Common Stock, shares outstanding	18,199,975	18,085,798

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
REVENUES
Rental income	$ 10,220	$ 7,338	$ 19,855	$ 13,956
Mortgage interest	0	258	0	519
Revenues	12,402	8,930	23,831	16,937
EXPENSES
Property operating	2,506	2,140	4,870	3,878
General and administrative	1,504	835	2,697	1,605
Depreciation and amortization	4,630	4,281	9,546	8,205
Bad debts	0	0	0	67
Expenses	8,640	7,256	17,113	13,755
OTHER INCOME (EXPENSE)
Interest expense	(1,571)	(1,209)	(2,839)	(1,806)
Other income (expense)	226	1	410	3
Other Income (Expense)	(1,345)	(1,208)	(2,429)	(1,803)
NET INCOME	$ 2,417	$ 466	$ 4,289	$ 1,379
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.12	$ 0.04	$ 0.22	$ 0.11
Net income per common share – Diluted (in dollars per share)	$ 0.12	$ 0.04	$ 0.22	$ 0.11
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	17,573,683	12,686,183	17,573,683	12,686,183
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	17,573,683	12,815,605	17,573,683	12,840,730
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD (in dollars per share)	$ 0.4	$ 0.39	$ 0.7975	$ 0.7775
Tenant reimbursements
REVENUES
Revenue	$ 1,590	$ 1,334	$ 3,030	$ 2,462
Other operating interest
REVENUES
Revenue	$ 592	$ 0	$ 946	$ 0

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 2,417	$ 466	$ 4,289	$ 1,379
Other comprehensive income (loss):
Increase (decrease) in fair value of cash flow hedges	720	(440)	1,626	(598)
Reclassification for amounts recognized as interest expense	87	156	155	162
Total other comprehensive income (loss)	807	(284)	1,781	(436)
COMPREHENSIVE INCOME	$ 3,224	$ 182	$ 6,070	$ 943

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Stockholders' Equity - 6 months ended Jun. 30, 2018 - USD ($) $ in Thousands	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]	Cumulative Net Income [Member]	Accumulated Other Comprehensive Income [Member]	Cumulative Dividends [Member]
Beginning Balance at Dec. 31, 2017	$ 283,374	$ 0	$ 181	$ 324,303	$ 4,775	$ 258	$ (46,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,417		1	1,416
Unrecognized gain on cash flow hedges	1,626					1,626
Reclassification adjustment for losses included in net income (interest expense)	155					155
Net income	4,289				4,289
Dividends to common stockholders ($0.7975 per share)	(14,503)						(14,503)
Ending Balance at Jun. 30, 2018	$ 276,358	$ 0	$ 182	$ 325,719	$ 9,064	$ 2,039	$ (60,646)

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)	6 Months Ended
	Jun. 30, 2018$ / shares
Cumulative Dividends [Member]
Dividends to common stockholders, per share (in dollars per share)	$ 0.7975

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
OPERATING ACTIVITIES
Net income	$ 4,289	$ 1,379
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,002	8,389
Stock-based compensation	1,417	653
Straight-line rent receivable	(807)	(535)
Straight-line rent liability	0	0
Provision for bad debts, net of recoveries	0	67
Reduction in contingent purchase price	0	(5)
Deferred income tax benefit	(112)	0
Changes in operating assets and liabilities:
Other assets	(1,309)	(641)
Accounts payable and accrued liabilities	287	(512)
Other liabilities	(739)	11
Net cash provided by operating activities	13,028	8,806
INVESTING ACTIVITIES
Acquisitions of real estate	(20,082)	(65,165)
Acquisitions of notes receivable	(2,201)	0
Funding of notes receivable	(4,833)	0
Proceeds from the repayment of notes receivable	34	294
Capital expenditures on existing real estate properties	(3,571)	(306)
Net cash used in investing activities	(30,653)	(65,177)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(8,000)	7,000
Term loan borrowings	40,000	60,000
Dividends paid	(14,503)	(10,189)
Debt issuance costs	(218)	(784)
Settlement of contingent purchase price	0	(393)
Net cash provided by financing activities	17,279	55,634
Decrease in cash and cash equivalents	(346)	(737)
Cash and cash equivalents, beginning of period	2,130	1,568
Cash and cash equivalents, end of period	1,784	831
Supplemental Cash Flow Information:
Interest paid	2,555	1,665
Invoices accrued for construction, tenant improvement and other capitalized costs	265	3
Reclassification between accounts and notes receivable	0	476
Increase (decrease) in fair value of cash flow hedges	1,626	(598)
Fair value of property received in foreclosure	4,541	0
Notes and mortgage receivable repayments utilized to originate note receivable (See footnote 5)	$ 18,167	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. As of June 30, 2018 , the Company had investments of approximately $416.8 million in 91 real estate properties, located in 27 states, totaling approximately 2.1 million square feet in the aggregate. Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2018 . All material intercompany accounts and transactions have been eliminated. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates. Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company may record income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT. Effective January 1, 2018, under legislation from the Tax Cuts and Jobs Act of 2017, the maximum U.S. federal corporate income tax rate was reduced from 35% to 21%. Accordingly, to the extent that the activities of our taxable REIT subsidiary generates taxable income in future periods, it may be subject to lower U.S. federal income tax rates. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses. New Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which establishes a comprehensive model to account for revenues arising from contracts with customers. ASU 2014-09 applies to all contracts with customers, except those that are within the scope of other topics in the FASB's Accounting Standards Codification, such as real estate leases and financial instruments. ASU 2014-09 requires companies to perform a five-step analysis of transactions to determine when and how revenue is recognized. The Company adopted ASU 2014-09 using the "modified retrospective" method effective January 1, 2018; as such, the Company applied the guidance only to the most recent period presented in the financial statements. The primary source of revenue for the Company is generated through its leasing arrangements with its tenants, which is covered under other accounting guidance, but certain non-lease revenues could be impacted by the new guidance. While the Company has not historically sold any properties, accounting for the sales of real estate could also be impacted by this new guidance. Prior to the adoption of ASU 2014-09, gains and losses from real estate sales were adjusted at the time of the sale by the maximum exposure to loss related to continuing involvement with the real estate. After adoption, any continuing involvement is considered a separate performance obligation and the sales price is required to be allocated between the elements with continuing involvement and those without continuing involvement. As the continuing performance obligations are satisfied, additional gains and losses will be recognized. The Company recognized no change to previously reported amounts from the cumulative effect of the adoption of ASU 2014-09. On January 1, 2018, the Company adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. The impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's total cash flows or its results of operations. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard. On January 1, 2018, the Company adopted ASU No. 2017-09, Compensation - Stock Compensation (Topic 718) , ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard. In February 2016, the FASB issued ASU No. 2016-02, Leases, ("ASU 2016-02"). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing lease. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Leasing revenues will continue to be recognized on a straight-line basis over the lease term, while certain reimbursable costs currently reflected on a net basis in the financial statements may require presentation on a gross basis under the new standard. Additionally, certain non-lease components may be accounted for under the new revenue recognition guidance in the revenue ASUs. The Company may also be impacted by this new accounting guidance related to ground leases in which the Company would be the lessee. Pursuant to the new accounting guidance, lessees are required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. In July 2018, the FASB finalized an amendment to ASC 842 that allows lessors to elect, as a practical expedient, not to allocate the total consideration to lease and non-lease components based on their relative stand-alone selling price. If adopted, the practical expedient will allow lessors to elect a combined single lease component presentation if (i) the timing and pattern of the revenue recognition of the combined single lease component is the same, and (ii) the related lease component and the combined single lease component would be classified as an operating lease. The amendment also provides a practical expedient that allows companies to use an optional transition method that will allow companies to record a cumulative adjustment to retained earnings during the period of adoption rather than restating prior periods. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

Real Estate Investments

Real Estate Investments	6 Months Ended
	Jun. 30, 2018
Real Estate [Abstract]
Real Estate Investments	Real Estate Investments At June 30, 2018 , the Company had investments of approximately $416.8 million in 91 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,608 $ 29,272 $ — $ 33,880 $ 3,300 Ohio 5 3,167 23,625 — 26,792 4,471 Texas 3 3,096 15,319 — 18,415 3,776 Illinois 2 1,134 11,823 — 12,957 2,018 Kansas 3 2,455 14,750 — 17,205 3,764 Iowa 1 2,241 9,009 — 11,250 1,675 Other states 14 3,641 27,631 — 31,272 3,284 33 20,342 131,429 — 151,771 22,288 Physician clinics: Kansas 2 610 6,921 — 7,531 1,176 Illinois 2 2,615 6,354 — 8,969 216 Florida 4 253 9,484 — 9,737 654 Other states 8 2,603 17,047 — 19,650 3,160 16 6,081 39,806 — 45,887 5,206 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 844 Michigan 2 628 8,275 — 8,903 2,151 Illinois 1 2,183 5,410 — 7,593 954 Florida 1 271 7,029 — 7,300 462 Arizona 2 576 5,389 — 5,965 1,253 Other states 7 2,122 17,835 — 19,957 3,240 14 7,463 65,291 — 72,754 8,904 Specialty centers: Illinois 3 3,482 24,716 — 28,198 823 Other states 17 3,214 31,329 — 34,543 5,704 20 6,696 56,045 — 62,741 6,527 Behavioral facilities: West Virginia 1 2,138 22,897 — 25,035 444 Illinois 1 1,300 18,803 — 20,103 980 Indiana 2 1,126 6,040 — 7,166 234 Other states 3 1,411 12,836 — 14,247 217 7 5,975 60,576 — 66,551 1,875 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 705 1 523 14,405 — 14,928 705 Corporate property — — 2,011 129 2,140 177 Total real estate investments 91 $ 47,080 $ 369,563 $ 129 $ 416,772 $ 45,682

Real Estate Leases

Real Estate Leases	6 Months Ended
	Jun. 30, 2018
Leases [Abstract]
Real Estate Leases	Real Estate Leases The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2034 . The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property. Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of June 30, 2018 , are as follows (in thousands): 2018 (six months ending December 31) $ 19,038 2019 35,367 2020 32,228 2021 28,950 2022 25,744 2023 and thereafter 149,899 $ 291,226 Straight-line rental income Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Straight-line rent included in rental income was approximately $0.4 million and $0.3 million , respectively, for the three months ended June 30, 2018 and 2017 and was approximately $0.8 million and $0.5 million , respectively, for the six months ended June 30, 2018 and 2017 . Deferred revenue Rent received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $ 1.2 million and $1.1 million , respectively, at June 30, 2018 and December 31, 2017 .

Real Estate Acquisitions

Real Estate Acquisitions	6 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
Real Estate Acquisitions	Real Estate Acquisitions Property Acquisitions During the second quarter of 2018, the Company acquired three real estate properties totaling approximately 68,000 square feet for an aggregate purchase price of approximately $11.7 million , including cash consideration of approximately $7.4 million and $4.5 million fair value of real estate received in foreclosure. Upon acquisition, two of the properties were 100% leased in the aggregate with lease expirations ranging from 2020 through 2026 , and one property previously secured a mortgage note receivable held by the Company. The property is subject to a signed term sheet to be leased to a single tenant as soon as the lease can be negotiated. See Note 5 for more detail on this property. Amounts reflected in revenues and net income for the three months ended June 30, 2018 for these properties was approximately $22,500 and $4,000 , respectively. Transaction costs totaling approximately $0.2 million related to these acquisitions were capitalized in the period and included in real estate assets. During the first quarter of 2018, the Company acquired three real estate properties totaling approximately 38,000 square feet for an aggregate purchase price and cash consideration of approximately $12.7 million . Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2018 through 2033 . Amounts reflected in revenues and net income for the six months ended June 30, 2018 for these properties was approximately $0.3 million and $0.3 million , respectively. Transaction costs totaling approximately $0.1 million related to these acquisitions were capitalized in the period and included in real estate assets.

Mortgage and Other Notes Receiv

Mortgage and Other Notes Receivable	6 Months Ended
	Jun. 30, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
Mortgage and Other Notes Receivable	Mortgage and Other Notes Receivable The Company had one mortgage note receivable outstanding as of December 31, 2017 with a principal balance of $10.6 million and interest receivable of $0.6 million . The borrower and several related entities (the "Borrower") filed for voluntary bankruptcy on June 23, 2017. At the time of filing for bankruptcy, the Borrower was current on all obligations to the Company, but no payments were received during the bankruptcy. On December 28, 2017, the Company purchased $11.45 million face value of certain promissory notes, secured by accounts receivable of the Borrower, for $8.75 million from a syndicate of banks, a $2.7 million discount to face value, and in the first quarter of 2018 acquired $2.2 million of certain promissory notes, secured by the operations of two facilities related to the Borrower, but were not included in the bankruptcy, for a total investment in these promissory notes of approximately $10.95 million . On April 25, 2018, the Company provided a $23.0 million loan, included in other assets, to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital that, along with a series of investments by the management of Newco, allowed Newco to acquire certain assets of the Borrower. Also on April 25, 2018, $10.95 million for the promissory notes discussed above and approximately $0.26 million of interest on those promissory notes and approximately $0.25 million in fees and reimbursement of expenses and approximately $6.7 million principal and accrued interest related to its mortgage note receivable were satisfied with proceeds from the loan. In addition, the Company received title to the property previously financed by the mortgage note receivable at an approximate $4.5 million valuation. No impairment was recognized by the Company.

Debt, net

Debt, net	6 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Debt, net	Debt, net The table below details the Company's debt as of June 30, 2018 and December 31, 2017 . Balance as of (Dollars in thousands) June 30, 2018 December 31, 2017 Maturity Dates Revolving Credit Facility $ 26,000 $ 34,000 8/19 5-Year Term Loan, net 49,722 29,685 3/22 7-Year Term Loan, net 49,695 29,668 3/24 $ 125,417 $ 93,353 The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, the lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility provides for a $150.0 million revolving credit facility (the "Revolving Credit Facility") and $100.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million , including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12 -month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five -year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a seven -year term loan facility in the aggregate principal amount of $50.0 million (the "7-Year Term Loan") which matures on March 29, 2024 . During the first quarter of 2018, the Company entered into two amendments relating to its Credit Facility. The first amendment, which was effective as of November 1, 2017, modified the formula used to calculate the amount of restricted payments the Company may make under the Credit Facility. The second amendment, effective on March 27, 2018, reduced the pricing margins on its LIBOR borrowings on both its Revolving Credit Facility and Term Loans and increased the maximum swingline commitment from $15.0 million to $20.0 million . The Company paid $0.2 million in fees related to these amendments. Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.75% to 2.50% or (ii) a base rate plus 0.75% to 1.50% , in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. At June 30, 2018 , the Company had $26.0 million outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $124.0 million and a weighted average interest rate of approximately 4.6% . Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.95% to 2.65% or (ii) a base rate plus 0.95% to 1.65% , in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company entered into interest rate swaps to fix the interest rates on the original Term Loan amounts drawn in 2017. On March 29, 2018, the Company borrowed the remaining $40.0 million , in equal amounts, available under its 5-Year and 7-Year Term Loans, repaid $40.0 million of its Revolving Credit Facility, and concurrently entered into interest rate swap agreements that fixed the interest rates on the additional $40.0 million drawn, resulting in fixed interest rates under the Term Loans ranging from 4.5790% to 4.6255% . See Note 7 for more details on the interest rate swaps. At June 30, 2018 , the Company had drawn the full $100.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.45% . The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization. The Company was in compliance with its financial covenants under its Credit Facility as of June 30, 2018 .

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract. As of June 30, 2018 , the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $100.0 million . The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 . Asset Derivatives Fair Value at June 30, 2018 December 31, 2017 Balance Sheet Classification Interest rate swaps $ 2,039 $ 258 Other assets The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.1 million will be reclassified from other comprehensive income ("OCI") as a decrease to interest expense. The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2018 and 2017 . Three Months Ended June 30, Six Months Ended June 30, (Dollars in thousands) 2018 2017 2018 2017 Amount of unrealized gain (loss) recognized in OCI on derivative $ 720 $ (440 ) $ 1,626 $ (598 ) Amount of loss reclassified from accumulated OCI into interest expense $ 87 $ 156 $ 155 $ 162 Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 1,571 $ 1,209 $ 2,839 $ 1,806

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2018
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2018 and for the year ended December 31, 2017 : Six Months Ended Year Ended December 31, 2017 Balance, beginning of period 18,085,798 12,988,482 Issuance of common stock — 4,887,500 Restricted stock-based awards 114,177 209,816 Balance, end of period 18,199,975 18,085,798 Equity Offering On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.6 million after deducting underwriting discount and commissions and offering expenses paid by the Company.

Net Income Per Common Share

Net Income Per Common Share	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Net Income Per Common Share	Net Income Per Common Share The following table sets forth the computation of basic and diluted net income per common share. Three Months Ended Six Months Ended (Dollars in thousands, except per share data) 2018 2017 2018 2017 Net income $ 2,417 $ 466 $ 4,289 $ 1,379 Participating securities' share in earnings (241 ) — (481 ) — Net income, less participating securities' share in earnings $ 2,176 $ 466 $ 3,808 $ 1,379 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 18,187,718 13,108,974 18,175,990 13,099,382 Unvested restricted shares (614,035 ) (422,791 ) (602,307 ) (413,199 ) Weighted average Common Shares outstanding–Basic 17,573,683 12,686,183 17,573,683 12,686,183 Weighted average Common Shares outstanding–Basic 17,573,683 12,686,183 17,573,683 12,686,183 Dilutive potential common shares — 129,422 — 154,547 Weighted average Common Shares outstanding –Diluted 17,573,683 12,815,605 17,573,683 12,840,730 Basic Net Income per Common Share $ 0.12 $ 0.04 $ 0.22 $ 0.11 Diluted Net Income per Common Share $ 0.12 $ 0.04 $ 0.22 $ 0.11

Incentive Plan

Incentive Plan	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Incentive Plan	Incentive Plan Under the Company's 2014 Incentive Plan, as amended, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended June 30, 2018 and 2017 was approximately $0.8 million and $0.3 million , respectively, and during the six months ended June 30, 2018 and 2017 was approximately $1.4 million and $0.7 million , respectively. Included in amortization expense for the second quarter of 2018 was approximately $0.2 million related to fully amortized shares previously granted to a board member who did not stand for re-election to the Company's board. A summary of the activity under the 2014 Incentive Plan for the three and six months ended June 30, 2018 and 2017 is included in the table below. Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Stock-based awards, beginning of period 606,116 419,070 512,115 302,299 Stock in lieu of compensation 5,320 4,843 52,347 64,128 Stock awards 14,856 11,067 61,830 68,553 Total stock granted 20,176 15,910 114,177 132,681 Stock-based awards, end of period 626,292 434,980 626,292 434,980

Other Assets

Other Assets	6 Months Ended
	Jun. 30, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 are detailed in the table below. Balance as of (Dollars in thousands) June 30, 2018 December 31, 2017 Notes receivable $ 28,050 $ 13,917 Accounts and interest receivables 2,748 2,417 Straight-line rent receivables 2,849 2,179 Allowance for doubtful accounts (191 ) (293 ) Prepaid assets 435 341 Deferred financing costs, net 586 618 Leasing commissions, net 539 483 Deferred tax asset 590 478 Fair value of interest rate swaps 2,039 258 Other 265 255 $ 37,910 $ 20,653 The Company's $28.1 million in notes receivable at June 30, 2018 include mainly the following notes. Interest related to these notes is included in Other Operating Income on the Company's Condensed Consolidated Statements of Income. • During 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. The $5.0 million note receivable, which matures on September 27, 2022, currently bears interest at 12% per annum, increasing through the maturity date to 16% per annum, and payments aggregating approximately $1.9 million are due each year until maturity with the remaining amount due at maturity. • On April 25, 2018, the Company provided a $23.0 million loan to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital that, along with a series of investments by the management of Newco, allowed Newco to acquire certain assets of the Borrower. The loan, which matures on May 1, 2031, currently bears interest at 9% per annum, with principal payments beginning in May 2021. See Note 5 for more details. The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at June 30, 2018 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 5.0 $ 5.0 Note receivable $ 23.0 $ 23.0

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value. Cash and cash equivalents - The carrying amount approximates the fair value. Mortgage note receivable - The fair value was estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company and are classified as level 2 in the hierarchy. Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy. Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates. Interest rate swaps - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy. The table below details the fair values and carrying values for our mortgage note and notes receivable and interest rate swaps at June 30, 2018 and December 31, 2017 , using level 2 inputs. June 30, 2018 December 31, 2017 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Mortgage note receivable $ — $ — $ 10,633 $ 10,633 Notes receivable $ 28,050 $ 28,048 $ 13,917 $ 13,828 Interest rate swap asset $ 2,039 $ 2,039 $ 258 $ 258

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend Declared On August 1, 2018 , the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.4025 per share. The dividend is payable on August 31, 2018 to stockholders of record on August 17, 2018 . Property Acquisition On July 30, 2018, the Company acquired a real estate property totaling approximately 17,000 square feet for a purchase price and cash consideration of approximately $3.5 million . The building was 100% leased at acquisition with lease expirations in 2023 .

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2018 . All material intercompany accounts and transactions have been eliminated.
Use of Estimates in the Condensed Consolidated Financial Statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.
Income Taxes	Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company may record income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT. Effective January 1, 2018, under legislation from the Tax Cuts and Jobs Act of 2017, the maximum U.S. federal corporate income tax rate was reduced from 35% to 21%. Accordingly, to the extent that the activities of our taxable REIT subsidiary generates taxable income in future periods, it may be subject to lower U.S. federal income tax rates. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.
New Accounting Pronouncements	New Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which establishes a comprehensive model to account for revenues arising from contracts with customers. ASU 2014-09 applies to all contracts with customers, except those that are within the scope of other topics in the FASB's Accounting Standards Codification, such as real estate leases and financial instruments. ASU 2014-09 requires companies to perform a five-step analysis of transactions to determine when and how revenue is recognized. The Company adopted ASU 2014-09 using the "modified retrospective" method effective January 1, 2018; as such, the Company applied the guidance only to the most recent period presented in the financial statements. The primary source of revenue for the Company is generated through its leasing arrangements with its tenants, which is covered under other accounting guidance, but certain non-lease revenues could be impacted by the new guidance. While the Company has not historically sold any properties, accounting for the sales of real estate could also be impacted by this new guidance. Prior to the adoption of ASU 2014-09, gains and losses from real estate sales were adjusted at the time of the sale by the maximum exposure to loss related to continuing involvement with the real estate. After adoption, any continuing involvement is considered a separate performance obligation and the sales price is required to be allocated between the elements with continuing involvement and those without continuing involvement. As the continuing performance obligations are satisfied, additional gains and losses will be recognized. The Company recognized no change to previously reported amounts from the cumulative effect of the adoption of ASU 2014-09. On January 1, 2018, the Company adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. The impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's total cash flows or its results of operations. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard. On January 1, 2018, the Company adopted ASU No. 2017-09, Compensation - Stock Compensation (Topic 718) , ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard. In February 2016, the FASB issued ASU No. 2016-02, Leases, ("ASU 2016-02"). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing lease. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Leasing revenues will continue to be recognized on a straight-line basis over the lease term, while certain reimbursable costs currently reflected on a net basis in the financial statements may require presentation on a gross basis under the new standard. Additionally, certain non-lease components may be accounted for under the new revenue recognition guidance in the revenue ASUs. The Company may also be impacted by this new accounting guidance related to ground leases in which the Company would be the lessee. Pursuant to the new accounting guidance, lessees are required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. In July 2018, the FASB finalized an amendment to ASC 842 that allows lessors to elect, as a practical expedient, not to allocate the total consideration to lease and non-lease components based on their relative stand-alone selling price. If adopted, the practical expedient will allow lessors to elect a combined single lease component presentation if (i) the timing and pattern of the revenue recognition of the combined single lease component is the same, and (ii) the related lease component and the combined single lease component would be classified as an operating lease. The amendment also provides a practical expedient that allows companies to use an optional transition method that will allow companies to record a cumulative adjustment to retained earnings during the period of adoption rather than restating prior periods. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

Real Estate Investments (Tables

Real Estate Investments (Tables)	6 Months Ended
	Jun. 30, 2018
Real Estate [Abstract]
Schedule of real estate property investments	At June 30, 2018 , the Company had investments of approximately $416.8 million in 91 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,608 $ 29,272 $ — $ 33,880 $ 3,300 Ohio 5 3,167 23,625 — 26,792 4,471 Texas 3 3,096 15,319 — 18,415 3,776 Illinois 2 1,134 11,823 — 12,957 2,018 Kansas 3 2,455 14,750 — 17,205 3,764 Iowa 1 2,241 9,009 — 11,250 1,675 Other states 14 3,641 27,631 — 31,272 3,284 33 20,342 131,429 — 151,771 22,288 Physician clinics: Kansas 2 610 6,921 — 7,531 1,176 Illinois 2 2,615 6,354 — 8,969 216 Florida 4 253 9,484 — 9,737 654 Other states 8 2,603 17,047 — 19,650 3,160 16 6,081 39,806 — 45,887 5,206 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 844 Michigan 2 628 8,275 — 8,903 2,151 Illinois 1 2,183 5,410 — 7,593 954 Florida 1 271 7,029 — 7,300 462 Arizona 2 576 5,389 — 5,965 1,253 Other states 7 2,122 17,835 — 19,957 3,240 14 7,463 65,291 — 72,754 8,904 Specialty centers: Illinois 3 3,482 24,716 — 28,198 823 Other states 17 3,214 31,329 — 34,543 5,704 20 6,696 56,045 — 62,741 6,527 Behavioral facilities: West Virginia 1 2,138 22,897 — 25,035 444 Illinois 1 1,300 18,803 — 20,103 980 Indiana 2 1,126 6,040 — 7,166 234 Other states 3 1,411 12,836 — 14,247 217 7 5,975 60,576 — 66,551 1,875 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 705 1 523 14,405 — 14,928 705 Corporate property — — 2,011 129 2,140 177 Total real estate investments 91 $ 47,080 $ 369,563 $ 129 $ 416,772 $ 45,682

Real Estate Leases (Tables)

Real Estate Leases (Tables)	6 Months Ended
	Jun. 30, 2018
Leases [Abstract]
Schedule of future minimum lease payments for operating leases	Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of June 30, 2018 , are as follows (in thousands): 2018 (six months ending December 31) $ 19,038 2019 35,367 2020 32,228 2021 28,950 2022 25,744 2023 and thereafter 149,899 $ 291,226

Debt, net (Tables)

Debt, net (Tables)	6 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Schedule of debt	The table below details the Company's debt as of June 30, 2018 and December 31, 2017 . Balance as of (Dollars in thousands) June 30, 2018 December 31, 2017 Maturity Dates Revolving Credit Facility $ 26,000 $ 34,000 8/19 5-Year Term Loan, net 49,722 29,685 3/22 7-Year Term Loan, net 49,695 29,668 3/24 $ 125,417 $ 93,353

Derivative Financial Instrume26

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of derivative instruments on balance sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 . Asset Derivatives Fair Value at June 30, 2018 December 31, 2017 Balance Sheet Classification Interest rate swaps $ 2,039 $ 258 Other assets
Schedule of derivative gain (loss)	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2018 and 2017 . Three Months Ended June 30, Six Months Ended June 30, (Dollars in thousands) 2018 2017 2018 2017 Amount of unrealized gain (loss) recognized in OCI on derivative $ 720 $ (440 ) $ 1,626 $ (598 ) Amount of loss reclassified from accumulated OCI into interest expense $ 87 $ 156 $ 155 $ 162 Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 1,571 $ 1,209 $ 2,839 $ 1,806

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2018
Equity [Abstract]
Schedule of reconciliation of common stock	The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2018 and for the year ended December 31, 2017 : Six Months Ended Year Ended December 31, 2017 Balance, beginning of period 18,085,798 12,988,482 Issuance of common stock — 4,887,500 Restricted stock-based awards 114,177 209,816 Balance, end of period 18,199,975 18,085,798

Net Income Per Common Share (Ta

Net Income Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the computation of basic and diluted net income per common share. Three Months Ended Six Months Ended (Dollars in thousands, except per share data) 2018 2017 2018 2017 Net income $ 2,417 $ 466 $ 4,289 $ 1,379 Participating securities' share in earnings (241 ) — (481 ) — Net income, less participating securities' share in earnings $ 2,176 $ 466 $ 3,808 $ 1,379 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 18,187,718 13,108,974 18,175,990 13,099,382 Unvested restricted shares (614,035 ) (422,791 ) (602,307 ) (413,199 ) Weighted average Common Shares outstanding–Basic 17,573,683 12,686,183 17,573,683 12,686,183 Weighted average Common Shares outstanding–Basic 17,573,683 12,686,183 17,573,683 12,686,183 Dilutive potential common shares — 129,422 — 154,547 Weighted average Common Shares outstanding –Diluted 17,573,683 12,815,605 17,573,683 12,840,730 Basic Net Income per Common Share $ 0.12 $ 0.04 $ 0.22 $ 0.11 Diluted Net Income per Common Share $ 0.12 $ 0.04 $ 0.22 $ 0.11

Incentive Plan (Tables)

Incentive Plan (Tables)	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of nonvested restricted stock activity	A summary of the activity under the 2014 Incentive Plan for the three and six months ended June 30, 2018 and 2017 is included in the table below. Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Stock-based awards, beginning of period 606,116 419,070 512,115 302,299 Stock in lieu of compensation 5,320 4,843 52,347 64,128 Stock awards 14,856 11,067 61,830 68,553 Total stock granted 20,176 15,910 114,177 132,681 Stock-based awards, end of period 626,292 434,980 626,292 434,980

Other Assets (Tables)

Other Assets (Tables)	6 Months Ended
	Jun. 30, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 are detailed in the table below. Balance as of (Dollars in thousands) June 30, 2018 December 31, 2017 Notes receivable $ 28,050 $ 13,917 Accounts and interest receivables 2,748 2,417 Straight-line rent receivables 2,849 2,179 Allowance for doubtful accounts (191 ) (293 ) Prepaid assets 435 341 Deferred financing costs, net 586 618 Leasing commissions, net 539 483 Deferred tax asset 590 478 Fair value of interest rate swaps 2,039 258 Other 265 255 $ 37,910 $ 20,653
Schedule of VIEs	The VIEs that we have identified at June 30, 2018 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 5.0 $ 5.0 Note receivable $ 23.0 $ 23.0

Fair Value of Financial Instr31

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The table below details the fair values and carrying values for our mortgage note and notes receivable and interest rate swaps at June 30, 2018 and December 31, 2017 , using level 2 inputs. June 30, 2018 December 31, 2017 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Mortgage note receivable $ — $ — $ 10,633 $ 10,633 Notes receivable $ 28,050 $ 28,048 $ 13,917 $ 13,828 Interest rate swap asset $ 2,039 $ 2,039 $ 258 $ 258

Summary of Significant Accoun32

Summary of Significant Accounting Policies - Business Overview/Segment Reporting (Details) ft² in Thousands, $ in Millions	Jun. 30, 2018USD ($)ft²statereal_estate_property	Mar. 31, 2018ft²
Accounting Policies [Abstract]
Value of real estate property investments and mortgages | $	$ 416.8
Number of real estate properties | real_estate_property	91
Number of states in which real estate investments are in | state	27
Area of real estate property (in square feet) | ft²	2,100	38

Real Estate Investments - Addit

Real Estate Investments - Additional Information (Details) $ in Millions	Jun. 30, 2018USD ($)real_estate_property
Real Estate [Abstract]
Value of real estate property investments and mortgages | $	$ 416.8
Number of real estate properties | real_estate_property	91

Real Estate Investments - Sched

Real Estate Investments - Schedule of Real Estate Property Investments (Details) $ in Thousands	Jun. 30, 2018USD ($)real_estate_property	Dec. 31, 2017USD ($)
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	91
Land and Land Improvements	$ 47,080	$ 44,419
Buildings, Improvements, and Lease Intangibles	369,563	343,955
Personal Property	129	112
Total real estate properties	416,772	388,486
Accumulated Depreciation	$ 45,682	$ 36,136
Medical office [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	33
Land and Land Improvements	$ 20,342
Buildings, Improvements, and Lease Intangibles	131,429
Total real estate properties	151,771
Accumulated Depreciation	$ 22,288
Medical office [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 4,608
Buildings, Improvements, and Lease Intangibles	29,272
Total real estate properties	33,880
Accumulated Depreciation	$ 3,300
Medical office [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,134
Buildings, Improvements, and Lease Intangibles	11,823
Total real estate properties	12,957
Accumulated Depreciation	$ 2,018
Medical office [Member] | Iowa [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,241
Buildings, Improvements, and Lease Intangibles	9,009
Total real estate properties	11,250
Accumulated Depreciation	$ 1,675
Medical office [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 2,455
Buildings, Improvements, and Lease Intangibles	14,750
Total real estate properties	17,205
Accumulated Depreciation	$ 3,764
Medical office [Member] | Ohio [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 3,167
Buildings, Improvements, and Lease Intangibles	23,625
Total real estate properties	26,792
Accumulated Depreciation	$ 4,471
Medical office [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	14
Land and Land Improvements	$ 3,641
Buildings, Improvements, and Lease Intangibles	27,631
Total real estate properties	31,272
Accumulated Depreciation	$ 3,284
Medical office [Member] | Texas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,096
Buildings, Improvements, and Lease Intangibles	15,319
Total real estate properties	18,415
Accumulated Depreciation	$ 3,776
Physician clinics [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	16
Land and Land Improvements	$ 6,081
Buildings, Improvements, and Lease Intangibles	39,806
Total real estate properties	45,887
Accumulated Depreciation	$ 5,206
Physician clinics [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 253
Buildings, Improvements, and Lease Intangibles	9,484
Total real estate properties	9,737
Accumulated Depreciation	$ 654
Physician clinics [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 2,615
Buildings, Improvements, and Lease Intangibles	6,354
Total real estate properties	8,969
Accumulated Depreciation	$ 216
Physician clinics [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 610
Buildings, Improvements, and Lease Intangibles	6,921
Total real estate properties	7,531
Accumulated Depreciation	$ 1,176
Physician clinics [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	8
Land and Land Improvements	$ 2,603
Buildings, Improvements, and Lease Intangibles	17,047
Total real estate properties	19,650
Accumulated Depreciation	$ 3,160
Surgical Centers and Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	14
Land and Land Improvements	$ 7,463
Buildings, Improvements, and Lease Intangibles	65,291
Total real estate properties	72,754
Accumulated Depreciation	$ 8,904
Surgical Centers and Hospitals [Member] | Arizona [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 576
Buildings, Improvements, and Lease Intangibles	5,389
Total real estate properties	5,965
Accumulated Depreciation	$ 1,253
Surgical Centers and Hospitals [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 271
Buildings, Improvements, and Lease Intangibles	7,029
Total real estate properties	7,300
Accumulated Depreciation	$ 462
Surgical Centers and Hospitals [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,183
Buildings, Improvements, and Lease Intangibles	5,410
Total real estate properties	7,593
Accumulated Depreciation	$ 954
Surgical Centers and Hospitals [Member] | Louisiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,683
Buildings, Improvements, and Lease Intangibles	21,353
Total real estate properties	23,036
Accumulated Depreciation	$ 844
Surgical Centers and Hospitals [Member] | Michigan [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 628
Buildings, Improvements, and Lease Intangibles	8,275
Total real estate properties	8,903
Accumulated Depreciation	$ 2,151
Surgical Centers and Hospitals [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	7
Land and Land Improvements	$ 2,122
Buildings, Improvements, and Lease Intangibles	17,835
Total real estate properties	19,957
Accumulated Depreciation	$ 3,240
Specialty Centers [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	20
Land and Land Improvements	$ 6,696
Buildings, Improvements, and Lease Intangibles	56,045
Total real estate properties	62,741
Accumulated Depreciation	$ 6,527
Specialty Centers [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,482
Buildings, Improvements, and Lease Intangibles	24,716
Total real estate properties	28,198
Accumulated Depreciation	$ 823
Specialty Centers [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	17
Land and Land Improvements	$ 3,214
Buildings, Improvements, and Lease Intangibles	31,329
Total real estate properties	34,543
Accumulated Depreciation	$ 5,704
Behavioral facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	7
Land and Land Improvements	$ 5,975
Buildings, Improvements, and Lease Intangibles	60,576
Total real estate properties	66,551
Accumulated Depreciation	$ 1,875
Behavioral facilities [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,300
Buildings, Improvements, and Lease Intangibles	18,803
Total real estate properties	20,103
Accumulated Depreciation	$ 980
Behavioral facilities [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,126
Buildings, Improvements, and Lease Intangibles	6,040
Total real estate properties	7,166
Accumulated Depreciation	$ 234
Behavioral facilities [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 1,411
Buildings, Improvements, and Lease Intangibles	12,836
Total real estate properties	14,247
Accumulated Depreciation	$ 217
Behavioral facilities [Member] | West Virginia [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,138
Buildings, Improvements, and Lease Intangibles	22,897
Total real estate properties	25,035
Accumulated Depreciation	$ 444
Long-Term Acute Care Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 705
Long-Term Acute Care Hospitals [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 705
Corporate property [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	0
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	2,011
Personal Property	129
Total real estate properties	2,140
Accumulated Depreciation	$ 177

Real Estate Leases (Details)

Real Estate Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Real Estate [Line Items]
2018 (six months ending December 31)	$ 19,038		$ 19,038
2,019	35,367		35,367
2,020	32,228		32,228
2,021	28,950		28,950
2,022	25,744		25,744
2023 and thereafter	149,899		149,899
Total	291,226		291,226
Straight Line rent	400	$ 300	807	$ 535
Other Liabilities [Member]
Real Estate [Line Items]
Deferred revenue	$ 1,200		$ 1,200		$ 1,100

Real Estate Acquisitions (Detai

Real Estate Acquisitions (Details) ft² in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018USD ($)ft²real_estate_property	Mar. 31, 2018USD ($)ft²real_estate_property	Jun. 30, 2018USD ($)ft²	Jun. 30, 2017USD ($)	Dec. 31, 2017real_estate_property
Business Acquisition [Line Items]
Number of properties acquired | real_estate_property	3	3
Area of real estate property (in square feet) | ft²	2,100	38	2,100
Consideration transferred	$ 11,700,000	$ 12,700,000
Cash consideration	7,400,000
Fair value of property received in foreclosure	$ 4,500,000		$ 4,541,000	$ 0
Number of properties leased at acquisition | real_estate_property	2
Percentage of properties that were leased at acquisition	100.00%	100.00%
Number of properties that previously secured mortgage note receivable | real_estate_property					1
Transaction costs	$ 200,000	$ 100,000	$ 200,000
Revenue from properties acquired	22,500	300,000
Net income from properties acquired	$ 4,000	$ 300,000
Acquisition Of Three Properties During Second Quarter 2018
Business Acquisition [Line Items]
Area of real estate property (in square feet) | ft²	68		68

Mortgage and Other Notes Rece37

Mortgage and Other Notes Receivable (Details) $ in Thousands	Apr. 25, 2018USD ($)hospital	Dec. 28, 2017USD ($)real_estate_property	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Dec. 31, 2017USD ($)mortgage_note_receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage note receivable, net			$ 0		$ 10,633
Notes receivable			28,050		13,917
Proceeds from the repayment of notes receivable			34	$ 294
Funding of notes receivable			2,201	$ 0
Repayments of mortgage note payable	$ 6,700
Real estate property			371,090		$ 352,350
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of mortgage note receivables | mortgage_note_receivable					1
Promissory Notes, Secured by Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage loans on real estate, face amount of mortgages		$ 11,450
Notes receivable		8,750
Receivable with imputed interest, discount		$ 2,700
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	23,000		$ 2,200
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable					$ 5,000
Proceeds from the repayment of notes receivable	10,950
Proceeds from the repayment of notes receivable, interest	260
Proceeds from the repayment of notes receivable, fees and expenses	$ 250
Other Assets [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest receivable					$ 600
Long-Term Acute Care Facility [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Specialty Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | real_estate_property		2
Property Previously Financed By Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate property	$ 4,500

Debt, net - Schedule of Debt (D

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Debt, net	$ 125,417	$ 93,353
Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	100,000
Revolving Credit Facility [Member] | Line of Credit [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	26,000	34,000
5 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	49,722	29,685
7 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	$ 49,695	$ 29,668

Debt, net - Narrative (Details)

Debt, net - Narrative (Details)	Mar. 29, 2018USD ($)	Mar. 29, 2017USD ($)option	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Mar. 27, 2018USD ($)	Mar. 26, 2018USD ($)	Dec. 31, 2017USD ($)
Line of Credit Facility [Line Items]
Debt issuance costs			$ 218,000	$ 784,000
Amount outstanding			125,417,000				$ 93,353,000
Draw on term loan borrowings			$ 40,000,000	$ 60,000,000
Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Debt repaid	$ 40,000,000
Swingline Commitment [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity					$ 20,000,000	$ 15,000,000
Second Amended And Restated Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum percentage of total book capitalization			40.00%
Second Amended And Restated Credit Facility [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount		$ 100,000,000
Unused borrowing commitment fee percentage		0.35%
Amount outstanding			$ 100,000,000
Draw on term loan borrowings	$ 40,000,000
Weighted average interest rate percentage			4.45%
Second Amended And Restated Credit Facility [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Fixed rate	4.579%
Second Amended And Restated Credit Facility [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Fixed rate	4.6255%
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		1.95%
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		2.65%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		0.95%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		1.65%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 150,000,000
Number of options to extend | option		2
Length of extension		12 months
Amount outstanding			$ 26,000,000				34,000,000
Weighted average interest rate percentage			4.60%
Remaining borrowing capacity			$ 124,000,000
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		1.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		2.50%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		0.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage		1.50%
Second Amended And Restated Credit Facility [Member] | Credit Facility, Accordion Feature [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 450,000,000
Second Amended And Restated Credit Facility [Member] | 5 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount		$ 50,000,000
Debt term		5 years
Amount outstanding			49,722,000				29,685,000
Second Amended And Restated Credit Facility [Member] | 7 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount		$ 50,000,000
Debt term		7 years
Amount outstanding			$ 49,695,000				$ 29,668,000
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage		0.25%
Percentage of borrowing capacity outstanding		33.30%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage		0.35%
Percentage of borrowing capacity outstanding		33.30%

Derivative Financial Instrume40

Derivative Financial Instruments - Narrative (Details) $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 0.1
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	4
Notional amount	$ 100

Derivative Financial Instrume41

Derivative Financial Instruments - Fair Value Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Derivatives, Fair Value [Line Items]
Derivative asset	$ 2,039	$ 258
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset	$ 2,039	$ 258

Derivative Financial Instrume42

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract [Member] - Cash Flow Hedging [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized gain (loss) recognized in OCI on derivative	$ 720	$ (440)	$ 1,626	$ (598)
Amount of loss reclassified from accumulated OCI into interest expense	87	156	155	162
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 1,571	$ 1,209	$ 2,839	$ 1,806

Stockholders' Equity - Reconcil

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	18,085,798	12,988,482
Issuance of common stock (in shares)	0	4,887,500
Restricted stock-based awards (in shares)	114,177	209,816
Balance, end of period (in shares)	18,199,975	18,085,798

Stockholders' Equity - Equity O

Stockholders' Equity - Equity Offering (Details) - Common Stock [Member] $ in Millions	Jul. 26, 2017USD ($)shares
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock | $	$ 108.6
Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued in transaction (shares)	4,887,500
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued in transaction (shares)	637,500

Net Income Per Common Share (De

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Earnings Per Share [Abstract]
Net income	$ 2,417	$ 466	$ 4,289	$ 1,379
Participating securities' share in earnings	(241)	0	(481)	0
Net income, less participating securities' share in earnings	$ 2,176	$ 466	$ 3,808	$ 1,379
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	18,187,718	13,108,974	18,175,990	13,099,382
Unvested restricted shares (in shares)	(614,035)	(422,791)	(602,307)	(413,199)
Weighted average Common Shares outstanding–Basic (in shares)	17,573,683	12,686,183	17,573,683	12,686,183
Weighted average Common Shares outstanding–Basic (in shares)	17,573,683	12,686,183	17,573,683	12,686,183
Dilutive effect of restricted stock (in shares)	0	129,422	0	154,547
Weighted average Common Shares outstanding –Diluted (in shares)	17,573,683	12,815,605	17,573,683	12,840,730
Basic Net Income per Common Share (in dollars per share)	$ 0.12	$ 0.04	$ 0.22	$ 0.11
Diluted Net Income per Common Share (in dollars per share)	$ 0.12	$ 0.04	$ 0.22	$ 0.11

Incentive Plan - Narrative (Det

Incentive Plan - Narrative (Details) - 2014 Incentive Plan [Member] - Restricted Common Stock [Member] - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0.8	$ 0.3	$ 1.4	$ 0.7
Board of Directors Chairman [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense		$ 0.2

Incentive Plan - Restricted Sto

Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan [Member] - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	606,116	419,070	512,115	302,299
Granted (in shares)	20,176	15,910	114,177	132,681
Stock-based awards, end of period (in shares)	626,292	434,980	626,292	434,980
Restricted Common Stock, Stock in Lieu of Compensation [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	5,320	4,843	52,347	64,128
Restricted Common Stock, Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	14,856	11,067	61,830	68,553

Other Assets - Other Assets (De

Other Assets - Other Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 28,050	$ 13,917
Accounts and interest receivables	2,748	2,417
Straight-line rent receivables	2,849	2,179
Allowance for doubtful accounts	(191)	(293)
Prepaid assets	435	341
Deferred financing costs, net	586	618
Leasing commissions, net	539	483
Deferred tax asset	590	478
Fair value of interest rate swaps	2,039	258
Other	265	255
Other assets, net	$ 37,910	$ 20,653

Other Assets - Narrative (Detai

Other Assets - Narrative (Details) $ in Thousands	Apr. 25, 2018USD ($)hospital	Dec. 31, 2017USD ($)	Jun. 30, 2018USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 13,917	$ 28,050
Note receivable, payments due		1,900
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 5,000
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 23,000		$ 2,200
Note receivable interest rate	9.00%
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate		12.00%
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate		16.00%
Long-Term Acute Care Facility [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Inpatient Rehabilitation Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1

Other Assets - VIEs (Details)

Other Assets - VIEs (Details) - Variable Interest Entity, Not Primary Beneficiary [Member] $ in Millions	Jun. 30, 2018USD ($)
Notes Receivable [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 5
Maximum Exposure to Loss	5
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Variable Interest Entity [Line Items]
Carrying Amount	23
Maximum Exposure to Loss	$ 23

Fair Value of Financial Instr51

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	$ 0	$ 10,633
Notes receivable	28,050	13,917
Interest rate swap asset	2,039	258
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	0	10,633
Notes receivable	28,050	13,917
Carrying Value [Member] | Interest Rate Swap [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	2,039	258
Fair Value [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	0	10,633
Notes receivable	28,048	13,828
Fair Value [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	$ 2,039	$ 258

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, ft² in Thousands, $ in Millions	Aug. 01, 2018$ / shares	Jul. 30, 2018USD ($)ft²	Jun. 30, 2018USD ($)ft²$ / shares	Mar. 31, 2018USD ($)ft²	Jun. 30, 2017$ / shares	Jun. 30, 2018ft²$ / shares	Jun. 30, 2017$ / shares
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares			$ 0.4		$ 0.39	$ 0.7975	$ 0.7775
Area of real estate property (in square feet) | ft²			2,100	38		2,100
Consideration transferred | $			$ 11.7	$ 12.7
Percentage of properties that were leased at acquisition			100.00%	100.00%
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares	$ 0.4025
Area of real estate property (in square feet) | ft²		17
Consideration transferred | $		$ 3.5
Percentage of properties that were leased at acquisition		100.00%